Gilbert Bernier, PhD
Alain Rheault, MBA, CFA, CPA
Anthony Flamier, MSC
STEMAXON TM is a Canadian biotechnology company located in the Greater Montréal Area which specializes in stem cell technology.
STEMAXON TM cumulative IP, starting with the only proven human sporadic AD model (patent pending) and AD-cascade related compounds (patent pending) greatly advance drug development and testing in the treatment and early stage diagnostics of Alzheimer’ disease.
STEMAXON TM has been nominated as a finalist for the ADRIQ's ''26th INNOVATION AWARD''.
STEMAXON TM Legal partners are Fasken Martineau.
ADVANCED RESEARCH FOR LIFE